| Product Name | Ginsenoside Rb2 |
|---|---|
| CAS | 11021-13-9 |
| Formula | C53H90O22 |
| MW | 1079.27 |
| Appearance | 白色粉末 |
| Melting point | 197-199 °C |
| Boiling point | 1117.1±65.0 °C | Condition: Press: 760 Torr |
| PKa | 12.85±0.70 | Condition: Most Acidic Temp: 25 °C |
| Product Name | Ginsenoside Rb2 |
|---|---|
| CAS | 11021-13-9 |
| Formula | C53H90O22 |
| MW | 1079.27 |
| Appearance | 白色粉末 |
| Melting point | 197-199 °C |
| Boiling point | 1117.1±65.0 °C | Condition: Press: 760 Torr |
| PKa | 12.85±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000464
中文名稱(chēng)：人參皂苷Rb2
中文別名：人參皂甙RB2
英文名稱(chēng)：Ginsenoside Rb2
英文別名：(3β,12β)-20-[(6-O-α-L-Arabinopyranosyl-β-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside;Dammarane, β-D-glucopyranoside deriv.;Ginsenoside C;Ginsenoside Rb2;NSC 308878;
分子式：C53H90O22
分子量：1079.27
CAS號(hào)：11021-13-9
純度：HPLC≥98%
熔點(diǎn)：197-199 °C
沸點(diǎn)：1117.1±65.0 °C | Condition: Press: 760 Torr
密度：1.42±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)：12.85±0.70 | Condition: Most Acidic Temp: 25 °C
儲(chǔ)存條件：-20℃，干燥、避光、密封
規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶需求包裝
供應(yīng)單位：四川省維克奇生物科技有限公司
供應(yīng)電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類(lèi)標(biāo)準(zhǔn)品和天然植物有效單體，主打中藥對(duì)照品/標(biāo)準(zhǔn)品/天然植物有效單體，化學(xué)合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲(chóng)草系列等，敬請(qǐng)關(guān)注！ 新批次有現(xiàn)貨，歡迎咨詢。
| An integrated strategy of MS-network-based offline 2DLC-QTOF-MS/MS coupled with UHPLC-QTRAP®-MS/MS for the characterization and quantification of the non-polysaccharides in Sijunzi decoction | ||
| Source:SCI：ANALYTICAL AND BIOANALYTICAL CHEMISTRY | Author:Dong, Bangjian | Notes：影響因子：4.157 |
| Reference description | ||
Liquiritin apioside, liquiritin, neoliquiritin, isoliquiritin apioside, isoliquiritin, ononin, naringin, liquiritigenin, poricoic acid A, poricoic acid B, poricoic acid C, glycyrrhetinic acid, dehydropachymic acid, pachymic acid, ginsenoside Re, ginsenoside Rg1, ginsenoside Rf, isoliquiritigenin, ginsenoside Rb1, ginsenoside Rg2, ginsenoside Rg3, ginsenoside Rg5, 20(S)-ginsenoside Rh1, notoginsenoside R1, ginsenoside Ro, ginsenoside Rc, formononetin, ginsenoside Rb2, glycyrrhizic acid, ginsenoside Rd, ginsenoside Rk1, and atractylenolide III were purchased from Chengdu DeSiTe Biological Technology Co., Ltd. (Chengdu, China) or Sichuan Weikeqi Biological Technology Co., Ltd. (Chengdu, China). | ||
| Structure–inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs) | ||
| Source:SCI：TOXICOLOGY AND APPLIED PHARMACOLOGY | Author:Zhong-Ze Fang | Notes：影響因子：3.975 |
| Reference description | ||
Recombinant human UGT isoforms (UGT1A1, UGT1A6, UGT1A7, UGT1A8, UGT1A9, UGT1A10, UGT2B7, UGT2B15) expressed in baculovirus-infected insect cells were obtained from BD Gentest Corp. (Woburn, MA, USA). Ginsenosides Rb1, Rb2, Rc, Rd, Rg3, Rh2, C-K, ppd, ppt, Re, Rg1, Rh1, F1, and F2 were purchased from Sichuan Weikeqi Biotechnology Company (Chengdu, Sichuan, China). The purity of these compounds was above 95%. All other reagents were of HPLC grade or of the highest grade commercially available. | ||
